Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00387491 · ClinicalTrials.gov registry record · Phase 1

Dose Ranging Study in Healthy Methadone Maintenance Subjects

A Phase 1 study of Adult, sponsored by Bausch Health Americas.

Completed
Registry status
Phase 1
Development phase
16
Enrollment target
1
Study location

NCT00387491: Completed Phase 1 study of Adult, sponsored by Bausch Health Americas.

NCT00387491 is a Phase 1 study of Adult that has completed, run by Bausch Health Americas. The registered enrollment target is 16 participants, below the 182-participant average among 10 other Adult trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00387491, a Phase 1 study of Adult, has completed, sponsored by Bausch Health Americas.

COMPLETED
Registry status
Phase 1
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.

Conditions Studied

Interventions

  • DRUG MOA-728

Study Locations (1)

Kansas

  • - Lenexa

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2006-06
Est. Completion 2006-10
Phase Phase 1
Bausch Health Americas

168 total trials

What the finished NCT00387491 record still lists

NCT00387491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 182-participant average among 10 other Adult trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Adult appearing as the primary indexed condition, and to 1 intervention - of which MOA-728 is the first listed.

NCT00387491 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT00387491 about?

NCT00387491 is a clinical study titled "Dose Ranging Study in Healthy Methadone Maintenance Subjects". To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.

What is the current status of trial NCT00387491?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2006-06. Estimated completion is 2006-10.

What conditions does trial NCT00387491 study?

This clinical trial studies the following conditions: Adult.

What interventions are being tested in trial NCT00387491?

The interventions under investigation include: MOA-728 (DRUG).

Who is sponsoring clinical trial NCT00387491?

This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00387491 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adult

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00387491's enrollment target sits among peer trials

16 11th of 10 the lowest of 10 other Adult trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00387491, the US trial registry maintained by the National Library of Medicine. NCT00387491 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.